Ken Griffin’s Apyx Medical APYX Stock Holding History

Ken Griffin’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,000	Closed	-$1.37K	–	12427
2025 Q1	$1.37K	Buy	+1,000	New	+$1.38K	﹤0.01%	14138
2024 Q4	–	Sell	-1,600	Closed	-$1.98K	–	14453
2024 Q3	$1.98K	Buy	1,600 +600	+60%	+$758	﹤0.01%	13790
2024 Q2	$1.34K	Hold	1,000	–	–	﹤0.01%	13829
2024 Q1	$1.36K	Sell	1,000 -300	-23%	-$638	﹤0.01%	14139
2023 Q4	$3.41K	Sell	1,300 -1,300	-50%	-$3.15K	﹤0.01%	13601
2023 Q3	$8.32K	Buy	2,600 +700	+37%	+$3.26K	﹤0.01%	13198
2023 Q2	$9.56K	Buy	1,900 +900	+90%	+$4.56K	﹤0.01%	13252
2023 Q1	$2.88K	Buy	1,000 +900	+900%	+$2.63K	﹤0.01%	14100
2022 Q4	$234	Buy	+100	New	+$305	﹤0.01%	14717
2022 Q3	–	Sell	-26,600	Closed	-$156K	–	12545
2022 Q2	$156K	Buy	+26,600	New	+$136K	﹤0.01%	10947

Other funds holding APYX

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Ken Griffin's APYX Position: Q1 2026 in Review

Ken Griffin opened a new position in Apyx Medical (APYX) in Q1 2026: 107,798 shares worth $398K. The stake represents ﹤0.01% of the portfolio and ranks #9825 among its holdings. This is a return to the name: Ken Griffin previously reported a position in APYX as recently as Q3 2025.

Ken Griffin first reported a position in APYX in Q1 2016 and has held it in 24 quarters since. The position peaked at $689K in Q3 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

Ken Griffin held 107,798 shares of Apyx Medical worth $398K as of Q1 2026.
Apyx Medical was a new Ken Griffin position in Q1 2026.
Apyx Medical made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #9825 holding.
Ken Griffin first reported a position in Apyx Medical in Q1 2016 and has held it in 24 quarters since.
Ken Griffin's Apyx Medical position peaked at $689K in Q3 2021.
67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.